Fernando Bril

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Topics

African American

Top Venues

Obesity (Silver Spring, Md.)

The Journal of clinical endocrinology and metabolism

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Mina Amiri, Sana Hatoum, Dawnkimberly Hopkins, Richard P Buyalos, Uche Ezeh, Lauren A Pace, Fernando Bril, Ali Sheidaei, Ricardo Azziz
The Association between Obesity and Polycystic Ovary Syndrome: An Epidemiologic Study of Observational Data. The Journal of clinical endocrinology and metabolism (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Lauren A Pace, Daniela Markovic, Richard Buyalos, Fernando Bril, Ricardo Azziz
Economic Burden of Endometrial Cancer Associated With Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Erin Petrie, Meagan Gray, Fernando Bril
Metabolic characteristics of patients with MetALD: Caveats of a new definition. Liver international : official journal of the International Association for the Study of the Liver (2024)
Fernando Bril, Lauren Pace, Ricardo Azziz
Response to Letter to the Editor From de Zegher and Ibáñez: "Adipose Tissue Dysfunction in Polycystic Ovary Syndrome". The Journal of clinical endocrinology and metabolism (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Fernando Bril, Meagan Gray
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race. Obesity (Silver Spring, Md.) 32 (3) (2023)
Fernando Bril, Meagan Gray
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race. Obesity (Silver Spring, Md.) (2023)
Fernando Bril, Meagan Gray
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race. Obesity (Silver Spring, Md.) 32 (3) (2023)
Fernando Bril, Meagan Gray
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race. Obesity (Silver Spring, Md.) 32 (3) (2023)
Fernando Bril, Meagan Gray
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race. Obesity (Silver Spring, Md.) 32 (3) (2023)
Fernando Bril, Meagan Gray
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race. Obesity (Silver Spring, Md.) 32 (3) (2023)
Fernando Bril, Meagan Gray
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race. Obesity (Silver Spring, Md.) (2023)
Fernando Bril, Meagan Gray
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race. Obesity (Silver Spring, Md.) 32 (3) (2023)
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, Kenneth Cusi
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence. Diabetes, obesity & metabolism (2022)
Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Romina Lomonaco, Xiaofei Chi, Sulav Shrestha, Rachel Dillard, Jeffery Budd, Jessica Portillo Romero, Christina Li, Fernando Bril, George Samraj, John Pennington, Petra Townsend, Frank Orlando, Shwetha Shetty, Lydia Mansour, Lorena Rodrigues Silva-Sombra, Pierre Bedossa, John Malaty, Diana Barb, Matthew J Gurka, Kenneth Cusi
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients with Type 2 Diabetes and NAFLD. The Journal of clinical endocrinology and metabolism (2022)
Yonghui Wu, Xi Yang, Heather Lynne Morris, Matthew J Gurka, Elizabeth A Shenkman, Kenneth Cusi, Fernando Bril, William Troy Donahoo
Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores. JMIR medical informatics 10 (6) (2022)
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, Kenneth Cusi
Pioglitazone Discontinuation in Patients with Nonalcoholic Steatohepatitis (NASH) Is Associated with Disease Recurrence. Diabetes, obesity & metabolism (2022)
Fernando Bril, Ryan W Pearce, Timothy S Collier, Michael J McPhaul
Differences in HDL-Bound Apolipoproteins in Patients with Advanced Liver Fibrosis due to Nonalcoholic Fatty Liver Disease. The Journal of clinical endocrinology and metabolism (2022)
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, Kenneth Cusi
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence. Diabetes, obesity & metabolism 25 (4) (2022)
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, Kenneth Cusi
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence. Diabetes, obesity & metabolism 25 (4) (2022)
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, Kenneth Cusi
Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence. Diabetes, obesity & metabolism 25 (4) (2022)
Kristin Alexandra Dayton, Fernando Bril, Diana Barb, Jinping Lai, Srilaxmi Kalavalapalli, Kenneth Cusi
Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes. PloS one 16 (6) (2021)
Fernando Bril, Michael J McPhaul, Srilaxmi Kalavalapalli, Romina Lomonaco, Diana Barb, Meagan E Gray, Dov Shiffman, Charles M Rowland, Kenneth Cusi
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes. The Journal of clinical endocrinology and metabolism 106 (11) (2021)
Francesco Rubino, Silvia Sabatini, Fabrizia Carli, Melania Gaggini, Fernando Bril, Renata Belfort-DeAguiar, Vincenzo Positano, Diana Barb, Sushma Kadiyala, Stephen A Harrison, Kenneth Cusi
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Scott Farley, Robert Ousley, Nicholas Van Wagoner, Fernando Bril
Autoimmunity after Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A. Thrombosis and haemostasis 121 (12) (2021)
Fernando Bril, Diana Julie Leeming, Morten Asser Karsdal, Srilaxmi Kalavalapalli, Diana Barb, Jinping Lai, Matthew Rabe, Kenneth Cusi
Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes. Diabetes care 42 (7) (2019)
Fernando Bril, Michael J McPhaul, Michael P Caulfield, Virginia C Clark, Consuelo Soldevilla-Pico, Roberto J Firpi-Morell, Jinping Lai, Carmen H Tong, Charles M Rowland, Kenneth Cusi
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes. Diabetes care 43 (2) (2019)
Fernando Bril, Diane M Biernacki, Srilaxmi Kalavalapalli, Romina Lomonaco, Sreevidya K Subbarayan, Jinping Lai, Fermin Tio, Amitabh Suman, Beverly K Orsak, Joan Hecht, Kenneth Cusi
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes care 42 (8) (2019)
Fernando Bril, Michael J McPhaul, Michael P Caulfield, Jean-Marie Castille, Thierry Poynard, Consuelo Soldevila-Pico, Virginia C Clark, Roberto J Firpi-Morell, Jinping Lai, Kenneth Cusi
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 67 (2) (2018)
Paola Portillo-Sanchez, Fernando Bril, Romina Lomonaco, Diana Barb, Beverly Orsak, Jan Marie Bruder, Kenneth Cusi
Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial. Journal of diabetes 11 (3) (2018)